ASPG and acute lymphoblastic leukemia: Asparaginase is considered a critical component used for the treatment of childhood ALL and can give rise to complete remission in 40%–60% of patients, while the 5-year OS in older patients (>60 years old) is still poor, even less than 20% (25–27).